PR
PreveCeutical Medical Inc.
PRVCF · OTC
$0.02 +11.38% (+$0.00)
1M -3.33%
Market Cap $12.1M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
57 /100
Average ROA 109.38%
Asset turnover 0.00x
ROIC 339.03%
Debt
0 /100
High Int. coverage -10.44x
Current ratio 0.15x
Net debt/EBITDA N/A
Stability
39 /100
Moderate EPS volatility 19.88%
Profitable years 0
Beta 0.07x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o PRVCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Van Deventer
Employees
7
Headquarters
Vancouver